PCNP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.555800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.585400E-01
Normal-vs-Stage2
4.101800E-01
Normal-vs-Stage3
9.896500E-03
Normal-vs-Stage4
5.861000E-01
Stage1-vs-Stage2
7.654800E-01
Stage1-vs-Stage3
5.112400E-02
Stage1-vs-Stage4
2.190000E-01
Stage2-vs-Stage3
1.418160E-01
Stage2-vs-Stage4
7.460000E-02
Stage3-vs-Stage4
3.750100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.424400E-01
Normal-vs-AfricanAmerican
7.791400E-01
Normal-vs-Asian
2.083600E-01
Caucasian-vs-AfricanAmerican
5.584200E-01
Caucasian-vs-Asian
2.955400E-01
AfricanAmerican-vs-Asian
2.836600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.365400E-01
Normal-vs-Female
5.024200E-01
Male-vs-Female
5.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.468000E-02
Normal-vs-Age(41-60Yrs)
9.095000E-01
Normal-vs-Age(61-80Yrs)
3.237800E-01
Normal-vs-Age(81-100Yrs)
3.589600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.613400E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.755600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.423200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.795700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.540840E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.770200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.754210E-01
Normal-vs-Daily Drinker
1.244350E-01
Normal-vs-Weekly Drinker
1.216410E-01
Normal-vs-Occasional Drinker
9.218400E-01
Normal-vs-Social Drinker
5.874600E-01
Non Drinker-vs-Daily Drinker
7.334200E-01
Non Drinker-vs-Weekly Drinker
6.612600E-01
Non Drinker-vs-Occasional Drinker
5.990300E-02
Non Drinker-vs-Social Drinker
3.314400E-01
Daily Drinker-vs-Weekly Drinker
8.878600E-01
Daily Drinker-vs-Occasional Drinker
4.228400E-02
Daily Drinker-vs-Social Drinker
2.490000E-01
Weekly Drinker-vs-Occasional Drinker
4.273900E-02
Weekly Drinker-vs-Social Drinker
2.751400E-01
Occasional Drinker-vs-Social Drinker
3.296800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.895410E-01
Normal-vs-Grade 2
4.216200E-02
Normal-vs-Grade 3
8.207900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.858600E-01
Grade 1-vs-Grade 3
5.415200E-01
Grade 1-vs-Grade 4
1.895410E-01
Grade 2-vs-Grade 3
9.550800E-01
Grade 2-vs-Grade 4
4.216200E-02
Grade 3-vs-Grade 4
8.207900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.039200E-01
Normal-vs-NonDiabetic
4.207800E-01
Diabetic-vs-NonDiabetic
2.638400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.217600E-02
Normal-vs-NoPancreatitis
4.210800E-01
Pancreatitis-vs-NoPancreatitis
2.605600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.423400E-01
Normal-vs-N1
4.400600E-01
N0-vs-N1
8.738600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.210600E-01
Normal-vs-TP53-NonMutant
5.679600E-01
TP53-Mutant-vs-TP53-NonMutant
2.624400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
